Junife Burguillos, PA
Physician Assistant · Millbrae
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Offices
- 2
Offices
2 locations · Robert Marriott Medical Corp · County of Santa Clara
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Junife Burguillos’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
California Medical Board record
Licence C17715 · Cancelled
Licence status: Cancelled · since 1956 · Case Western Reserve University School of Medicine.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$2,629
Medicare paid this office $2,629 for 12 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Procedures Medicare counted
| Removal of nail tissue | 1-10 | None |
| Removal of skin lesions | 1-10 | None |
| Removal of tissue | 1-10 | None |
Who their Medicare patients are
12 Original Medicare patients in 2024. Average age 71 · Health risk score 11.32. Sicker patients than 9 in 10 peers; the typical physician assistant clinician is at 1.31.
Conditions among them: High blood pressure 75% · Diabetes 75% · Chronic kidney disease 75%.
The office billed $28,459, Medicare allowed $3,300 and paid $2,629; for 31 services of 4 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Medicaid work
$48,691 in 2024
Medicaid paid $48,691 for 544 billed services this clinician did in 2024, up to 81 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 325 | $48,691 |
| Short return visit (20+ min) | 33 | $0 |
| Return visit (30+ min) | 174 | $0 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 12 | $0 |
| 2024 | 544 | 4 | 81 | $48,691 |
| 2023 | 2,397 | 13 | 180 | $215,582 |
| 2022 | 3,892 | 14 | 196 | $321,589 |
| 2021 | 5,407 | 14 | 204 | $420,107 |
| 2020 | 4,634 | 14 | 190 | $350,485 |
| 2019 | 2,977 | 14 | 139 | $325,443 |
| 2018 | 3,326 | 10 | 221 | $387,463 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 1,296 | $213,924 |
| Thyroid stimulating hormone (TSH) | 17 | $405 |
| Blood test, lipids (cholesterol and triglycerides) | 14 | $266 |
| Measurement of free thyroxine | 17 | $217 |
| COMPREHENSIVE METABOLIC PANEL | 14 | $210 |
| Hemoglobin A1C level | 14 | $193 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 15 | $165 |
| Short return visit (20+ min) | 204 | $142 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, with microscopy | 14 | $62 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 13 | $0 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure) | 12 | $0 |
| Return visit (30+ min) | 755 | $0 |
2022
| Clinic visit/encounter, all-inclusive | 1,967 | $315,057 |
| Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 21 | $1,575 |
| Thyroid stimulating hormone (TSH) | 46 | $1,095 |
| Measurement of vitamin D 25 hydroxy | 28 | $996 |
| Blood test, lipids (cholesterol and triglycerides) | 40 | $759 |
| Measurement of free thyroxine | 46 | $587 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 46 | $507 |
| COMPREHENSIVE METABOLIC PANEL | 30 | $449 |
| Hemoglobin A1C level | 29 | $399 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, without microscopy | 34 | $108 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, with microscopy | 13 | $57 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 14 | $0 |
2021
| Clinic visit/encounter, all-inclusive | 2,561 | $409,634 |
| Thyroid stimulating hormone (TSH) | 94 | $2,199 |
| Measurement of vitamin D 25 hydroxy | 58 | $2,027 |
| Blood test, lipids (cholesterol and triglycerides) | 77 | $1,433 |
| COMPREHENSIVE METABOLIC PANEL | 85 | $1,252 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 113 | $1,228 |
| Measurement of free thyroxine | 93 | $1,167 |
| Hemoglobin A1C level | 59 | $805 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, without microscopy | 114 | $361 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 39 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 12 | $0 |
| New patient visit (45+ min) | 13 | $0 |
2020
| Clinic visit/encounter, all-inclusive | 2,110 | $333,957 |
| Measurement of vitamin D 25 hydroxy | 98 | $3,485 |
| Thyroid stimulating hormone (TSH) | 139 | $3,261 |
| Blood test, lipids (cholesterol and triglycerides) | 105 | $1,973 |
| COMPREHENSIVE METABOLIC PANEL | 121 | $1,781 |
| Measurement of free thyroxine | 138 | $1,737 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 137 | $1,488 |
| Hemoglobin A1C level | 109 | $1,485 |
| Short return visit (20+ min) | 806 | $862 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, without microscopy | 147 | $457 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 14 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 16 | $0 |
2019
| Clinic visit/encounter, all-inclusive | 2,021 | $321,038 |
| Measurement of vitamin D 25 hydroxy | 31 | $1,031 |
| Blood test, lipids (cholesterol and triglycerides) | 42 | $759 |
| Thyroid stimulating hormone (TSH) | 31 | $690 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 46 | $485 |
| COMPREHENSIVE METABOLIC PANEL | 31 | $434 |
| Hemoglobin A1C level | 28 | $385 |
| Measurement of free thyroxine | 30 | $358 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, without microscopy | 86 | $263 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 31 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 39 | $0 |
| Short return visit (20+ min) | 497 | $0 |
2018
| Clinic visit/encounter, all-inclusive | 2,418 | $373,541 |
| Measurement of vitamin D 25 hydroxy | 78 | $2,774 |
| Thyroid stimulating hormone (TSH) | 98 | $2,285 |
| Blood test, lipids (cholesterol and triglycerides) | 120 | $2,236 |
| COMPREHENSIVE METABOLIC PANEL | 131 | $1,897 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 141 | $1,507 |
| Hemoglobin A1C level | 108 | $1,485 |
| Measurement of free thyroxine | 98 | $1,226 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, without microscopy | 121 | $370 |
| Culture, bacterial; quantitative colony count, urine | 13 | $142 |
Drugs they prescribed that Part D paid
$3,445
Pharmacies billed $3,445 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 163) in 2024. At or below the middle of the specialty; the typical physician assistant clinician is at 1%.
156 generic and fewer than 11 brand-name prescriptions · $3,445 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Gabapentin | 11 | $192 | $17 |
| Levothyroxine | 14 | $185 | $13 |
| Lisinopril | 21 | $103 | $5 |
| Atorvastatin | 17 | $73 | $4 |
| Simvastatin | 12 | $37 | $3 |
Year by year
| 2024 | 163 | 24 | 0% (0) | None | $3,445 |
| 2023 | 298 | 39 | None | 8% | $22,276 |
| 2022 | 444 | 58 | None | None | $20,369 |
| 2021 | 669 | 75 | 4% (29) | 7% | $23,441 |
| 2020 | 857 | 117 | 4% (36) | 10% | $48,821 |
| 2019 | 1,020 | 164 | 5% (49) | 7% | $34,772 |
| 2018 | 960 | 162 | 6% (57) | None | $29,475 |
| 2017 | 1,098 | 191 | 6% (64) | 12% | $38,905 |
| 2016 | 1,086 | 209 | 6% (67) | None | $49,274 |
| 2015 | 1,201 | 221 | 10% (115) | None | $40,674 |
| 2014 | 433 | 85 | 6% (26) | None | $16,103 |
| 2013 | 16 | None | 88% (14) | None | $614 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 8 drugs
| Prevacid | 12 | $10,533 | $878 |
| Atorvastatin | 29 | $634 | $22 |
| Losartan | 14 | $518 | $37 |
| Lisinopril | 28 | $468 | $17 |
| Levothyroxine | 21 | $405 | $19 |
| Atenolol | 14 | $306 | $22 |
| Metformin | 17 | $207 | $12 |
| Amlodipine Besylate | 12 | $153 | $13 |
2022: 13 drugs
| Prevacid | 12 | $10,759 | $897 |
| Gabapentin | 15 | $742 | $49 |
| Levothyroxine | 29 | $535 | $18 |
| Atorvastatin | 40 | $499 | $12 |
| Losartan | 20 | $413 | $21 |
| Lisinopril | 35 | $332 | $9 |
| Metformin | 13 | $158 | $12 |
| Metformin Hcl Er | 13 | $157 | $12 |
| Simvastatin | 15 | $136 | $9 |
| Atenolol | 11 | $118 | $11 |
| Fluticasone Propionate | 13 | $104 | $8 |
| Amlodipine Besylate | 21 | $74 | $4 |
| Triamcinolone Acetonide | 18 | $66 | $4 |
2021: 17 drugs
| Butalbital-Acetaminophen-Caffe | 13 | $3,379 | $260 |
| Acetaminophen-Codeine | 22 | $792 | $36 |
| Baclofen | 18 | $650 | $36 |
| Levothyroxine | 43 | $626 | $15 |
| Atorvastatin | 45 | $479 | $11 |
| Losartan | 30 | $427 | $14 |
| Diclofenac | 11 | $407 | $37 |
| Lisinopril | 54 | $372 | $7 |
| Omeprazole | 27 | $362 | $13 |
| Gabapentin | 15 | $198 | $13 |
| Metformin | 33 | $178 | $5 |
| Fluticasone Propionate | 20 | $158 | $8 |
| Amlodipine Besylate | 29 | $134 | $5 |
| Simvastatin | 22 | $107 | $5 |
| Metoprolol | 11 | $91 | $8 |
| Atenolol | 15 | $72 | $5 |
| Lisinopril-Hydrochlorothiazide | 12 | $58 | $5 |
2020: 21 drugs
| Albuterol Sulfate Hfa | 23 | $1,037 | $45 |
| Acetaminophen-Codeine | 25 | $777 | $31 |
| Atorvastatin | 60 | $660 | $11 |
| Levothyroxine | 27 | $573 | $21 |
| Losartan | 42 | $531 | $13 |
| Metformin | 66 | $481 | $7 |
| Lisinopril | 57 | $367 | $6 |
| Nitrofurantoin Mono-Macro | 11 | $337 | $31 |
| Baclofen | 11 | $273 | $25 |
| Triamterene-Hydrochlorothiazid | 12 | $236 | $20 |
| Omeprazole | 24 | $166 | $7 |
| Gabapentin | 14 | $159 | $11 |
| Amlodipine Besylate | 35 | $157 | $4 |
| Simvastatin | 22 | $157 | $7 |
| Duloxetine | 14 | $141 | $10 |
| Amoxicillin-Clavulanate Potass | 11 | $137 | $12 |
| Fluticasone Propionate | 13 | $100 | $8 |
| Metoprolol | 11 | $89 | $8 |
| Glipizide | 11 | $67 | $6 |
| Atenolol | 12 | $67 | $6 |
| Triamcinolone Acetonide | 13 | $54 | $4 |
2019: 28 drugs
| Atorvastatin | 83 | $1,154 | $14 |
| Ventolin Hfa | 12 | $696 | $58 |
| Acetaminophen-Codeine | 24 | $500 | $21 |
| Nitrofurantoin Mono-Macro | 15 | $465 | $31 |
| Levothyroxine | 40 | $439 | $11 |
| Gabapentin | 35 | $428 | $12 |
| Lisinopril | 51 | $384 | $8 |
| Losartan | 44 | $303 | $7 |
| Omeprazole | 22 | $288 | $13 |
| Metformin | 51 | $265 | $5 |
| Duloxetine | 12 | $245 | $20 |
| Amlodipine Besylate | 43 | $224 | $5 |
| Amoxicillin-Clavulanate Potass | 16 | $219 | $14 |
| Naproxen | 12 | $210 | $17 |
| Zolpidem | 35 | $189 | $5 |
| Losartan-Hydrochlorothiazide | 11 | $184 | $17 |
| Clotrimazole | 17 | $181 | $11 |
| Sertraline | 14 | $168 | $12 |
| Ibuprofen | 20 | $161 | $8 |
| Azithromycin | 23 | $156 | $7 |
| Triamcinolone Acetonide | 29 | $139 | $5 |
| Warfarin | 13 | $137 | $11 |
| Simvastatin | 19 | $117 | $6 |
| Tramadol | 15 | $85 | $6 |
| Sulfamethoxazole-Trimethoprim | 12 | $84 | $7 |
| Glipizide | 13 | $70 | $5 |
| Glimepiride | 11 | $61 | $6 |
| Clonazepam | 15 | $43 | $3 |
2018: 25 drugs
| Atorvastatin | 61 | $1,026 | $17 |
| Ventolin Hfa | 13 | $728 | $56 |
| Gabapentin | 40 | $710 | $18 |
| Hydrocodone-Acetaminophen | 27 | $659 | $24 |
| Duloxetine | 15 | $581 | $39 |
| Nitrofurantoin Mono-Macro | 19 | $500 | $26 |
| Lisinopril | 80 | $496 | $6 |
| Omeprazole | 36 | $381 | $11 |
| Metformin | 48 | $359 | $7 |
| Metoprolol | 11 | $358 | $33 |
| Amoxicillin-Clavulanate Potass | 11 | $351 | $32 |
| Pravastatin | 13 | $330 | $25 |
| Levothyroxine | 24 | $307 | $13 |
| Losartan | 38 | $251 | $7 |
| Simvastatin | 31 | $191 | $6 |
| Amlodipine Besylate | 38 | $173 | $5 |
| Tramadol | 18 | $150 | $8 |
| Azithromycin | 21 | $137 | $7 |
| Fluticasone Propionate | 13 | $134 | $10 |
| Acetaminophen-Codeine | 12 | $130 | $11 |
| Zolpidem | 26 | $123 | $5 |
| Atenolol | 13 | $121 | $9 |
| Metoprolol | 15 | $91 | $6 |
| Triamcinolone Acetonide | 14 | $81 | $6 |
| Hydrochlorothiazide | 11 | $58 | $5 |
2017: 32 drugs
| Lantus | 11 | $4,480 | $407 |
| Nitrofurantoin Mono-Macro | 27 | $732 | $27 |
| Proair Hfa | 12 | $684 | $57 |
| Atorvastatin | 42 | $559 | $13 |
| Hydrocodone-Acetaminophen | 29 | $510 | $18 |
| Levothyroxine | 19 | $459 | $24 |
| Lisinopril | 69 | $446 | $6 |
| Metformin | 45 | $362 | $8 |
| Baclofen | 16 | $340 | $21 |
| Simvastatin | 38 | $320 | $8 |
| Omeprazole | 47 | $304 | $6 |
| Pravastatin | 15 | $240 | $16 |
| Acetaminophen-Codeine | 17 | $232 | $14 |
| Gabapentin | 26 | $192 | $7 |
| Amlodipine Besylate | 48 | $179 | $4 |
| Amoxicillin-Clavulanate Potass | 14 | $177 | $13 |
| Azithromycin | 29 | $164 | $6 |
| Triamcinolone Acetonide | 23 | $159 | $7 |
| Losartan | 19 | $157 | $8 |
| Fluticasone Propionate | 15 | $142 | $9 |
| Ibuprofen | 28 | $139 | $5 |
| Warfarin | 17 | $130 | $8 |
| Zolpidem | 18 | $118 | $7 |
| Metoprolol | 20 | $91 | $5 |
| Tramadol | 15 | $81 | $5 |
| Naproxen | 14 | $78 | $6 |
| Hydrochlorothiazide | 19 | $65 | $3 |
| Lovastatin | 11 | $63 | $6 |
| Sulfamethoxazole-Trimethoprim | 15 | $62 | $4 |
| Atenolol | 26 | $57 | $2 |
| Alprazolam | 14 | $52 | $4 |
| Furosemide | 15 | $48 | $3 |
2016: 32 drugs
| Levemir | 13 | $3,569 | $275 |
| Hydrocodone-Acetaminophen | 41 | $1,457 | $36 |
| Nitrofurantoin Mono-Macro | 19 | $640 | $34 |
| Ventolin Hfa | 11 | $572 | $52 |
| Levothyroxine | 31 | $492 | $16 |
| Atorvastatin | 28 | $488 | $17 |
| Lisinopril | 75 | $443 | $6 |
| Metformin | 40 | $303 | $8 |
| Metoprolol | 14 | $290 | $21 |
| Gabapentin | 26 | $277 | $11 |
| Venlafaxine | 11 | $270 | $25 |
| Azithromycin | 38 | $240 | $6 |
| Finasteride | 16 | $211 | $13 |
| Triamcinolone Acetonide | 27 | $211 | $8 |
| Acetaminophen-Codeine | 11 | $210 | $19 |
| Simvastatin | 42 | $206 | $5 |
| Fluticasone Propionate | 18 | $192 | $11 |
| Ibuprofen | 32 | $184 | $6 |
| Amlodipine Besylate | 53 | $173 | $3 |
| Clopidogrel | 11 | $160 | $15 |
| Metoprolol | 32 | $143 | $4 |
| Warfarin | 19 | $141 | $7 |
| Losartan | 22 | $129 | $6 |
| Omeprazole | 24 | $126 | $5 |
| Hydrochlorothiazide | 13 | $109 | $8 |
| Lovastatin | 13 | $104 | $8 |
| Tramadol | 13 | $91 | $7 |
| Atenolol | 19 | $86 | $5 |
| Sulfamethoxazole-Trimethoprim | 12 | $66 | $6 |
| Famotidine | 11 | $50 | $5 |
| Furosemide | 12 | $26 | $2 |
| Prednisone | 11 | $22 | $2 |
2015: 26 drugs
| Hydrocodone-Acetaminophen | 50 | $1,206 | $24 |
| Proair Hfa | 23 | $1,167 | $51 |
| Levothyroxine | 31 | $652 | $21 |
| Carbamazepine | 11 | $601 | $55 |
| Methadone | 16 | $469 | $29 |
| Lisinopril | 82 | $427 | $5 |
| Metformin | 60 | $420 | $7 |
| Atorvastatin | 23 | $406 | $18 |
| Epitol | 11 | $389 | $35 |
| Omeprazole | 54 | $319 | $6 |
| Simvastatin | 65 | $312 | $5 |
| Gabapentin | 34 | $264 | $8 |
| Azithromycin | 34 | $211 | $6 |
| Losartan | 19 | $206 | $11 |
| Clopidogrel | 15 | $170 | $11 |
| Amlodipine Besylate | 35 | $159 | $5 |
| Ibuprofen | 24 | $151 | $6 |
| Warfarin | 23 | $143 | $6 |
| Hydrochlorothiazide | 31 | $104 | $3 |
| Metoprolol | 13 | $101 | $8 |
| Atenolol | 21 | $99 | $5 |
| Triamcinolone Acetonide | 13 | $99 | $8 |
| Tramadol | 19 | $90 | $5 |
| Carvedilol | 11 | $86 | $8 |
| Famotidine | 13 | $86 | $7 |
| Furosemide | 26 | $83 | $3 |
2014: 10 drugs
| Hydrocodone-Acetaminophen | 20 | $448 | $22 |
| Metformin | 34 | $249 | $7 |
| Simvastatin | 33 | $241 | $7 |
| Lisinopril | 35 | $190 | $5 |
| Ibuprofen | 17 | $146 | $9 |
| Atorvastatin | 11 | $120 | $11 |
| Cephalexin | 13 | $101 | $8 |
| Azithromycin | 11 | $79 | $7 |
| Amlodipine Besylate | 11 | $59 | $5 |
| Atenolol | 15 | $58 | $4 |
Money from drug and device companies
$18 in 2024
| 2024 | 1 | 1 | None | $18 |
| 2023 | 2 | 2 | None | $24 |
| 2022 | 4 | 5 | None | $103 |
| 2021 | 2 | 4 | None | $146 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| GlaxoSmithKline | Arexvy | $18 | 1 payment
|
See the published payment
| GlaxoSmithKline | Meals · 2024-12-03 | Arexvy | $18 |
See earlier years (2023, 2022, 2021)
2023: $24
| Sanofi Pasteur | Menquadfi | $19 | 1 payment
|
| Mayne Pharma Commercial | Nextstellis | $5 | 1 payment
|
2022: $103
| TherapeuticsMD | Annovera | $39 | 2 payments
|
| Abbvie | Mavyret | $29 | 1 payment
|
| Ethicon US | Vistaseal | $20 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $16 | 1 payment
|
2021: $146
| AbbVie | Mavyret | $86 | 1 payment
|
| TherapeuticsMD | Annovera | $60 | 3 payments
|
Professional record
- NPI
- 1992945901
- Licence
- CA 17715California C17715: Cancelled
- Group
- Robert Marriott Medical Corp · County of Santa Clara
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Physician assistant, medical (363AM0700X)
- Mailing address
- 2200 Del Paso Blvd, Sacramento, CA, 95815
- NPI first listed
- 2009-03-03
- NPI last updated
- 2009-03-03
This is when the NPI record was last certified, not a medical board exam.